Bracket Global LLC has acquired mobile technology solutions provider mProve Health Inc.
The acquisition enables the clinical trial technology and specialty services provider to support tech-enabled clinical trials.
Both the acquirer and target companies are based in the US.
“The new company combines Crestovo’s extensive IP assets with Finch’s commercial-scale manufacturing capabilities.”
Microbiome engineering company Finch Therapeutics and clinical-stage biopharmaceutical company Crestovo have merged to create a new entity named Finch Therapeutics Group.
The new company combines Crestovo’s extensive IP assets with Finch’s commercial-scale manufacturing capabilities.
Both companies involved in the merger are based in the US.
Share this article
